Select Medical Holdings Corporation
NYSE:SEMMedical - Care Facilities
+$0.02 today
- Market cap
- $2.05B
- Beta
- 0.79
- P/E (TTM)
- 15.3
- EPS (TTM)
- $1.08
- Dividend yield
- 1.51%
Volume 14.27M
Average 1.75M
SEM Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Select Medical Holdings CorporationNYSE: SEM
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $34.81M rose 0.0% year over year, ahead of the -24.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 3.9% from the prior quarter. Over 3 fiscal years it compounded at -12.0% a year.
Context
- Depreciation & amortization amounted to 2.6% of revenue in FY2025, down 1.4 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +0.0% holds above the trailing-twelve-month pace of -24.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 140.3M USD
- Year-over-year change
- -31.2%
- 4-year CAGR
- -8.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 140.3M | -31.2% |
| FY2024 | 2024-12-31 | 203.89M | -2.3% |
| FY2023 | 2023-12-31 | 208.74M | +1.4% |
| FY2022 | 2022-12-31 | 205.83M | +1.6% |
| FY2021 | 2021-12-31 | 202.65M | — |
Depreciation & Amortization vs competitors
How SEM compares with its peers on the latest reported figures
- SEM's LTM Mar 2026 depreciation & amortization of $140.3M is the 3rd largest of the 11 companies compared; the peer median is $39.61M.
- Its year-over-year change of -24.0% is the lowest of 11, against a peer median of +10.2%.
- Depreciation & amortization amounts to 2.5% of revenue for SEM, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $201.74M | +10.2% | +17.1% | 5.9% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $162.49M | +10.4% | +4.1% | 2.5% |
| LTM Mar 2026 | $140.3M | -24.0% | -12.0% | 2.5% | |
| LTM Jun 2026 | $54.56M | -5.2% | -7.5% | 3.4% | |
| LTM Mar 2026 | $54.38M | +83.2% | +37.6% | 1.5% | |
| LTM Sep 2026 | $49.13M | +10.2% | +3.5% | 3.1% | |
| LTM Oct 2026 | $30.08M | +6.5% | -10.1% | 1.1% | |
| LTM Jun 2026 | $25.34M | +6.1% | +2.7% | 2.6% | |
| LTM Sep 2026 | $23.78M | +3.1% | -15.1% | 1.2% | |
| LTM Mar 2026 | $22.52M | +10.1% | +14.9% | 3.1% | |
| LTM Mar 2026 | $16.75M | +12.2% | +3.7% | 0.9% | |
| Peer median (excluding SEM) | $39.61M | +10.2% | +3.6% | 2.6% | |
Competitors are the stored peer set for SEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 499.95M | 198.03M | 299.73M | 296.7M | 146.22M |
| Depreciation & Amortization | 202.65M | 205.83M | 208.74M | 203.89M | 140.3M |
| Deferred Income Tax | 5.06M | 7.52M | (16.12M) | (32.43M) | 30.65M |
| Stock-Based Compensation | 30.94M | 37.76M | 43.81M | 100.67M | 16.7M |
| Change in Working Capital | (329.98M) | (159.54M) | 59.5M | (55.14M) | (59.68M) |
| Accounts Receivables | 23.1M | (52.18M) | 1.16M | (95.85M) | (45.19M) |
| Inventory | (82.77M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 53.39M | (48.04M) | (6.41M) | (16.79M) | (854K) |
| Other Working Capital | (323.7M) | (59.31M) | 64.75M | 57.5M | (13.64M) |
| Other Non-Cash Items | (7.38M) | (4.76M) | (13.6M) | 4.17M | 72.27M |
| Operating Cash Flow | 401.23M | 284.83M | 582.06M | 517.86M | 346.47M |
| Capital Expenditures | (180.54M) | (190.37M) | (229.2M) | 21.78M | 36.27M |
| Acquisitions (Net) | (102.88M) | (44.31M) | (39.44M) | (13.1M) | (9.2M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 26.82M | 8.34M | 163K | 4.26M | (243.56M) |
| Investing Cash Flow | (256.59M) | (226.34M) | (268.48M) | (231.01M) | (216.49M) |
| Debt Repayment | 195.7M | 264.68M | (203.95M) | (493.46M) | 42.34M |
| Common Stock Issued | 0 | 0 | 0 | 511.2M | 0 |
| Common Stock Repurchased | (79.48M) | (195.53M) | (12.76M) | (37.91M) | (100.08M) |
| Dividends Paid | (50.6M) | (64.59M) | (63.9M) | (64.62M) | (31.44M) |
| Other Financing Activities | (713.01M) | (39.45M) | (46.86M) | (226.38M) | (73.98M) |
| Financing Cash Flow | (647.39M) | (34.89M) | (327.48M) | (311.17M) | (163.15M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (502.75M) | 23.6M | (13.9M) | (24.31M) | (33.17M) |
| Free Cash Flow | 220.69M | 94.45M | 352.86M | 539.65M | 382.74M |
Select Medical Holdings Corporation
NYSE:SEM
Intrinsic Alpha fair value
Locked
Current Price
$16.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.